1MED KN95 Particulate Respirator Mask
- Maximum Purchase:
- 10 units
- One Box Contains:
- 20 Masks
1MED presents the KN95 Particulate Respirator Mask, offering protection from airborne particles of up to 0.1um with greater than a 95% PFE. The ear loop design makes it easy and comfortable to wear while the nose bridge metal clip ensures your mask will stay secure and seal out the germs! Made of non-woven fabric with electrostatic filter cotton, these masks have shown to filter out at least 95% of particles in the air (up to 0.3 micron in size).
Available as individual masks or boxes of 20
PLEASE NOTE: This mask is suited for single use only, do not reuse. After use, please dispose of it properly to avoid contact by others. This mask is not suitable for work places with open flames and harsh dust environments. Readjust masks if air leak seems obvious, Stop use if you have trouble breathing after use or discontinue use after 4 hours.
ALL SALES ARE FINAL
- Pull and extend the mask using two hands and ensure the nose clip is facing upward
- Place the mask over the nose and mouth and secure by placing the elastic loops over ears
- Press the nose clip to secure the mask and adjust bands for secure seal
Protocatechuic Acid (PCA) is a natural ingredient found everywhere in nature and even in our everyday diet. Its unique formula has also shown to be an excellent source for 5 potential health benefits:
- BROAD-SPECTRUM ANTIBIOTIC
Medical researcher and orthopedic surgeon, Dr. Lanny Johnson, has spent over 15 years dedicated to the credible, evidence-based research conducted to test the effectiveness of PCA against a series of bacteria and viruses. PCA’s unique physical structure and medically-researched antiviral properties can provide a microbe shield, limiting the exposure to bacteria and viruses, including the virus causing COVID-19. As a result, 18 US patents were granted to Dr. Lanny Johnson which include those related to the antimicrobial properties of PCA.
18 US Patents for PCA - click here
Two independent contract laboratories conducted research at the Illinois Institute of Technology and MRI Global, Inc to help prove PCA as a viable reagent against Coronavirus when applied to various surfaces. Both of these studies resulted in greater than 90% inactivation of SARS CoV2 (COVID-19) while providing immediate inhibition of the virus and a continued residual shield for up to 24 hours.
PCA HAS THE POWER TO HELP MAINTAIN HEALTH AND THE POTENTIAL TO FIGHT MICROBES.